These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36578661)

  • 1. Respiratory support strategies in the prevention of bronchopulmonary dysplasia: A single center quality improvement initiative.
    White H; Merritt K; Martin K; Lauer E; Rhein L
    Front Pediatr; 2022; 10():1012655. PubMed ID: 36578661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital and Neurodevelopmental Outcomes in Nano-Preterm Infants Receiving Invasive vs Noninvasive Ventilation at Birth.
    Shukla VV; Souder JP; Imbrock G; Hu M; Rahman AKMF; Travers CP; Ambalavanan N; Carlo WA; Lal CV
    JAMA Netw Open; 2022 Aug; 5(8):e2229105. PubMed ID: 36036932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilation and respiratory outcome in extremely preterm infants: trends in the new millennium.
    Regin Y; Gie A; Eerdekens A; Toelen J; Debeer A
    Eur J Pediatr; 2022 May; 181(5):1899-1907. PubMed ID: 35034202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
    Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 9. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
    Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China.
    Han T; Liu H; Zhang H; Guo M; Zhang X; Duan Y; Sun F; Liu X; Zhang X; Zhang M; Liu F; Bao L; Xiao M; Liu W; Jiang R; Zheng J; Tian X; Gao Q; Zhang W; Guo W; Li L; Tong X
    Front Pediatr; 2020; 8():182. PubMed ID: 32457854
    [No Abstract]   [Full Text] [Related]  

  • 11. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.
    Morrow LA; Wagner BD; Ingram DA; Poindexter BB; Schibler K; Cotten CM; Dagle J; Sontag MK; Mourani PM; Abman SH
    Am J Respir Crit Care Med; 2017 Aug; 196(3):364-374. PubMed ID: 28249118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants.
    Sharma A; Xin Y; Chen X; Sood BG
    Pediatr Neonatol; 2020 Jun; 61(3):290-299. PubMed ID: 32217025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence.
    Poets CF; Lorenz L
    Arch Dis Child Fetal Neonatal Ed; 2018 May; 103(3):F285-F291. PubMed ID: 29363502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchopulmonary dysplasia in preterm infants managed with non-invasive ventilation or surfactant and a brief period of mechanical ventilation: a 6-year cohort study.
    König K; Guy KJ
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):608-11. PubMed ID: 23834679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing early invasive mechanical ventilation exposure in preterm infants: a quality improvement initiative.
    Welch B; Rose R; Myers J; Drayton Jackson M; Lien I; Barbato A
    J Perinatol; 2024 Aug; ():. PubMed ID: 39198555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g].
    Huang J; Lin XZ; Zheng Z; Wang L; Ou FF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1326-1333. PubMed ID: 36544414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Bronchopulmonary Dysplasia Among Extremely Preterm Infants in Japan, 2003-2016.
    Nakashima T; Inoue H; Sakemi Y; Ochiai M; Yamashita H; Ohga S;
    J Pediatr; 2021 Mar; 230():119-125.e7. PubMed ID: 33246013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.